Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
J Thorac Cardiovasc Surg. 2024 Mar;167(3):1064-1076.e2. doi: 10.1016/j.jtcvs.2023.07.012. Epub 2023 Jul 21.
This study aimed to investigate the clinical trends and the impact of the 2018 heart allocation policy change on both waitlist and post-transplant outcomes in simultaneous heart-kidney transplantation in the United States.
The United Network for Organ Sharing registry was queried to compare adult patients before and after the allocation policy change. This study included 2 separate analyses evaluating the waitlist and post-transplant outcomes. Multivariable analyses were performed to determine the 2018 allocation system's risk-adjusted hazards for 1-year waitlist and post-transplant mortality.
The initial analysis investigating the waitlist outcomes included 1779 patients listed for simultaneous heart-kidney transplantation. Of these, 1075 patients (60.4%) were listed after the 2018 allocation policy change. After the policy change, the waitlist outcomes significantly improved with a shorter waitlist time, lower likelihood of de-listing, and higher likelihood of transplantation. In the subsequent analysis investigating the post-transplant outcomes, 1130 simultaneous heart-kidney transplant recipients were included, where 738 patients (65.3%) underwent simultaneous heart-kidney transplantation after the policy change. The 90-day, 6-month, and 1-year post-transplant survival and complication rates were comparable before and after the policy change. Multivariable analyses demonstrated that the 2018 allocation system positively impacted risk-adjusted 1-year waitlist mortality (sub-hazard ratio, 0.66, 95% CI, 0.51-0.85, P < .001), but it did not significantly impact risk-adjusted 1-year post-transplant mortality (hazard ratio, 1.03; 95% CI, 0.72-1.47, P = .876).
This study demonstrates increased rates of simultaneous heart-kidney transplantation with a shorter waitlist time after the 2018 allocation policy change. Furthermore, there were improved waitlist outcomes and comparable early post-transplant survival after simultaneous heart-kidney transplantation under the 2018 allocation system.
本研究旨在探讨美国心脏-肾脏同期移植中,2018 年心脏分配政策改变对等待名单和移植后结果的临床趋势和影响。
通过联合器官共享网络(United Network for Organ Sharing)注册处查询,比较分配政策改变前后的成年患者。本研究包括 2 项分别评估等待名单和移植后结果的分析。采用多变量分析确定 2018 年分配系统对 1 年等待名单和移植后死亡率的风险调整危害。
最初分析等待名单结果包括 1779 例同时接受心脏-肾脏移植的患者。其中,1075 例(60.4%)在 2018 年分配政策改变后被列入名单。政策改变后,等待名单时间缩短,退出可能性降低,移植可能性增加,等待名单结果显著改善。在随后分析移植后结果中,包括 1130 例同期心脏-肾脏移植受者,其中 738 例(65.3%)在政策改变后同时接受心脏-肾脏移植。政策改变前后,90 天、6 个月和 1 年移植后生存率和并发症发生率相当。多变量分析表明,2018 年分配系统对风险调整的 1 年等待名单死亡率有积极影响(亚风险比,0.66,95%可信区间,0.51-0.85,P<0.001),但对风险调整的 1 年移植后死亡率无显著影响(危险比,1.03;95%可信区间,0.72-1.47,P=0.876)。
本研究表明,2018 年分配政策改变后,心脏-肾脏同期移植的比例增加,等待名单时间缩短。此外,在 2018 年分配系统下,同期心脏-肾脏移植的等待名单结果改善,早期移植后生存率相当。